Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Subscribe To Our Newsletter & Stay Updated
